How much funding has Satellite Bio raised?

Satellite Bio has raised $215.5M in total funding, most recently a Series B round.

Who are Satellite Bio's investors?

Satellite Bio's investors include aMoon, Alpha Wave Ventures, Alumni Ventures, Lightspeed VP, Section 32, Catalio Capital Management.

When was Satellite Bio founded?

Satellite Bio was founded in 2019.

Where is Satellite Bio headquartered?

Satellite Bio is headquartered in Cambridge, Massachusetts, United States.

What industry is Satellite Bio in?

Satellite Bio operates in Biotech, Life Sciences, Therapeutics, Healthcare.

How many employees does Satellite Bio have?

Satellite Bio has 11-50 employees.

Satellite Bio

formerly Satellite Biosciences

Unlocking the full potential of liver cells as medicine

Cambridge, United States · Founded 2019 · $215.5M raised

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: satellite.bio
Total Funding: $215.5M
Last Round: $95.0M Series BJan 2024
Rounds: 4

About

Satellite Bio is a Cambridge, Massachusetts-based biotech company pioneering tissue therapeutics. Its proprietary off-the-shelf liver therapy delivers functional hepatocytes into the body to engraft and restore liver function. The company raised $110M across seed and Series A rounds and emerged from stealth in 2022. It uses drug-like manufacturing for scalable, cost-effective global distribution.

Summary

Satellite Bio is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $215.5M in total across 4 rounds, most recently a $95.0M Series B round in Jan 2024. Investors include aMoon, Alpha Wave Ventures and Alumni Ventures.

LinkedIn X (Twitter)